Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

AHCC Activation and Selection of Human Lymphocytes via Genotypic and Phenotypic Changes to an Adherent Cell Type: A Possible Novel Mechanism of T Cell Activation.

Olamigoke L, Mansoor E, Mann V, Ellis I, Okoro E, Wakame K, Fuji H, Kulkarni A, Francoise Doursout M, Sundaresan A.

Evid Based Complement Alternat Med. 2015;2015:508746. doi: 10.1155/2015/508746. Epub 2015 Dec 15.

2.

Active Hexose Correlated Compound Activates Immune Function to Decrease Chlamydia trachomatis Shedding in a Murine Stress Model.

Belay T, Fu CL, Woart A.

J Nutr Med Diet Care. 2015;1(1). pii: JNMDC-1-006. Epub 2015 Sep 15.

3.

Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses.

Gao Y, Zhang D, Sun B, Fujii H, Kosuna K, Yin Z.

Cancer Immunol Immunother. 2006 Oct;55(10):1258-66. Epub 2005 Dec 16.

PMID:
16362410
4.

Short-term supplementation with active hexose correlated compound improves the antibody response to influenza B vaccine.

Roman BE, Beli E, Duriancik DM, Gardner EM.

Nutr Res. 2013 Jan;33(1):12-7. doi: 10.1016/j.nutres.2012.11.001. Epub 2012 Dec 4.

PMID:
23351405
5.

Low-dose supplementation with active hexose correlated compound improves the immune response to acute influenza infection in C57BL/6 mice.

Nogusa S, Gerbino J, Ritz BW.

Nutr Res. 2009 Feb;29(2):139-43. doi: 10.1016/j.nutres.2009.01.005.

PMID:
19285605
7.

Active hexose correlated compound exerts therapeutic effects in lymphocyte driven colitis.

Mascaraque C, Suárez MD, Zarzuelo A, Sánchez de Medina F, Martínez-Augustin O.

Mol Nutr Food Res. 2014 Dec;58(12):2379-82. doi: 10.1002/mnfr.201400364. Epub 2014 Oct 2.

PMID:
25186628
8.

Active hexose-correlated compound down-regulates HSP27 of pancreatic cancer cells, and helps the cytotoxic effect of gemcitabine.

Suenaga S, Kuramitsu Y, Kaino S, Maehara S, Maehara Y, Sakaida I, Nakamura K.

Anticancer Res. 2014 Jan;34(1):141-6.

PMID:
24403454
9.

Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma.

Matsushita K, Kuramitsu Y, Ohiro Y, Obara M, Kobayashi M, Li YQ, Hosokawa M.

Anticancer Drugs. 1998 Apr;9(4):343-50.

PMID:
9635925
10.

The nutritional supplement Active Hexose Correlated Compound (AHCC) has direct immunomodulatory actions on intestinal epithelial cells and macrophages involving TLR/MyD88 and NF-κB/MAPK activation.

Daddaoua A, Martínez-Plata E, Ortega-González M, Ocón B, Aranda CJ, Zarzuelo A, Suárez MD, de Medina FS, Martínez-Augustin O.

Food Chem. 2013 Feb 15;136(3-4):1288-95. doi: 10.1016/j.foodchem.2012.09.039. Epub 2012 Sep 23.

PMID:
23194525
11.

Active hexose correlated compound (AHCC) enhances resistance to infection in a mouse model of surgical wound infection.

Aviles H, O'Donnell P, Sun B, Sonnenfeld G.

Surg Infect (Larchmt). 2006 Dec;7(6):527-35.

PMID:
17233570
12.

Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: a double-blind, placebo-controlled trial.

Terakawa N, Matsui Y, Satoi S, Yanagimoto H, Takahashi K, Yamamoto T, Yamao J, Takai S, Kwon AH, Kamiyama Y.

Nutr Cancer. 2008;60(5):643-51. doi: 10.1080/01635580801993280.

PMID:
18791928
13.

Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice.

Shigama K, Nakaya A, Wakame K, Nishioka H, Fujii H.

J Exp Ther Oncol. 2009;8(1):43-51.

PMID:
19827270
14.

Effects of active hexose correlated compound on frequency of CD4+ and CD8+ T cells producing interferon-γ and/or tumor necrosis factor-α in healthy adults.

Yin Z, Fujii H, Walshe T.

Hum Immunol. 2010 Dec;71(12):1187-90. doi: 10.1016/j.humimm.2010.08.006. Epub 2010 Aug 21.

PMID:
20732368
15.

The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.

Hirose A, Sato E, Fujii H, Sun B, Nishioka H, Aruoma OI.

Toxicol Appl Pharmacol. 2007 Jul 15;222(2):152-8. Epub 2007 Apr 20.

PMID:
17555784
16.

Genotoxicity and subchronic toxicity evaluation of Active Hexose Correlated Compound (AHCC).

Fujii H, Nishioka N, Simon RR, Kaur R, Lynch B, Roberts A.

Regul Toxicol Pharmacol. 2011 Mar;59(2):237-50. doi: 10.1016/j.yrtph.2010.10.006. Epub 2010 Oct 14.

PMID:
20951179
17.

Suppressive effect of active hexose correlated compound (AHCC) on thymic apoptosis induced by dexamethasone in the rat.

Burikhanov RB, Wakame K, Igarashi Y, Wang S, Matsuzaki S.

Endocr Regul. 2000 Dec;34(4):181-8.

PMID:
11137978
18.
19.

Active hexose correlated compound potentiates the antitumor effects of low-dose 5-fluorouracil through modulation of immune function in hepatoma 22 tumor-bearing mice.

Cao Z, Chen X, Lan L, Zhang Z, Du J, Liao L.

Nutr Res Pract. 2015 Apr;9(2):129-36. doi: 10.4162/nrp.2015.9.2.129. Epub 2014 Dec 26.

20.

Prognostic improvement of patients with advanced liver cancer after active hexose correlated compound (AHCC) treatment.

Cowawintaweewat S, Manoromana S, Sriplung H, Khuhaprema T, Tongtawe P, Tapchaisri P, Chaicumpa W.

Asian Pac J Allergy Immunol. 2006 Mar;24(1):33-45.

Supplemental Content

Support Center